IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding IGC Pharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 4.45M | 4.81M | +356.5K (+8.0%) |
| Value | $7.97M | $7.90M | −$70.0K (−0.9%) |
New holders (7)
Institutions that held IGC Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 298,115 | $489.0K | 0.00% |
| State Street Corp | 216,878 | $356.0K | 0.00% |
| Virtu Financial LLC | 190,293 | $312.0K | 0.03% |
| Penserra Capital Management LLC | 56,068 | $98.0K | 0.00% |
| Two Sigma Securities, LLC | 32,228 | $53.0K | 0.01% |
| Squarepoint Ops LLC | 12,182 | $20.0K | 0.00% |
| Evermay Wealth Management LLC | 30 | $0 | 0.00% |
Sold out (7)
Institutions that held IGC Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Carroll Financial Associates, Inc. | 320,000 | $572.0K |
| Vontobel Holding Ltd. | 120,000 | $212.0K |
| Engineers Gate Manager LP | 22,800 | $41.0K |
| Barclays PLC | 537 | $1.00K |
| Capital Analysts, LLC | 307 | $1.00K |
| Abundance Wealth Counselors | 400 | $1.00K |
| Sowell Financial Services LLC | 105 | $0 |